Amneal Pharmaceuticals to Funnel up to USD 200 Million in India

Amneal Pharmaceuticals, a US company, announced plans to pour USD 200 million (around Rs 1,680 crore) into India for constructing two new manufacturing units in Ahmedabad within the next four to five years. The company announced plans for two new facilities: one for peptide synthesis and one for advanced sterile fill-finish manufacturing.

"In this latest expansion in India, Amneal will make a total net investment of between USD 150 million and USD 200 million over the next four to five years to build two new greenfield facilities," it said.

Commenting on the development, Amneal Pharmaceuticals Co-Founders and Co-Chief Executive Officers Chirag Patel and Chintu Patel said, "With these new facilities, we are proud to be at the forefront of developing and manufacturing innovative, branded medicines at scale in India, which will supply the local market and the rest of the world."

The business began operating in India in 2008 and now has a total of eight manufacturing sites, with five located in Ahmedabad and additional locations in Dahej, Hyderabad, and Vizag, along with offices in Mumbai. Over the last decade, around USD 600 million has been put into investments in India.

The company stated that these facilities can together produce around 60 million units of injectables and 8.5 billion tablets every year.